Table of Contents
1. Executive Summary
2. Market Background and Classifications
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. Market Trends and Forecast Analysis from 2018 to 2030
3.1: Macroeconomic Trends and Forecast
3.2: Global Interventional Cardiology and Peripheral Vascular Device Market Trends and Forecast
3.3: Global Interventional Cardiology and Peripheral Vascular Device Market by Type
3.3.1: Interventional Cardiology Devices
3.3.2: Peripheral Vascular Devices
3.4: Global Interventional Cardiology and Peripheral Vascular Device Market by Device
3.4.1: Angioplasty Balloons
3.4.2: Angioplasty Stents
3.4.3: Angioplasty Catheter
3.4.4: Intravascular Ultrasound System
3.4.5: Guidewires
3.4.6: Arteriotomy Closure Devices
3.4.7: EVAR Stent Graft
3.4.8: Inferior Vena Cava Filter
3.4.9: Embolic Protection Device
3.4.10: Synthetic Surgical Graft
3.5: Global Interventional Cardiology and Peripheral Vascular Device Market by End Use
4. Market Trends and Forecast Analysis by Region
4.1: Global Interventional Cardiology and Peripheral Vascular Device Market by Region
4.2: North American Interventional Cardiology and Peripheral Vascular Device Market
4.2.1: Market by Type: Interventional Cardiology Devices and Peripheral Vascular Devices
4.2.2: Market by Device: Interventional Cardiology Devices and Peripheral Vascular Devices
4.2.3: United States Interventional Cardiology and Peripheral Vascular Device Market
4.2.4: Canadian Interventional Cardiology and Peripheral Vascular Device Market
4.3: European Interventional Cardiology and Peripheral Vascular Device Market
4.3.1: Market by Type: Interventional Cardiology Devices and Peripheral Vascular Devices
4.3.2: Market by Device: Interventional Cardiology Devices and Peripheral Vascular Devices
4.3.3: German Interventional Cardiology and Peripheral Vascular Device Market
4.3.4: French Interventional Cardiology and Peripheral Vascular Device Market
4.3.5: Interventional Cardiology and Peripheral Vascular Device Market of the United Kingdom
4.3.6: Italian Interventional Cardiology and Peripheral Vascular Device Market
4.3.7: Spanish Interventional Cardiology and Peripheral Vascular Device Market
4.4: APAC Interventional Cardiology and Peripheral Vascular Device Market
4.4.1: Market by Type: Interventional Cardiology Devices and Peripheral Vascular Devices
4.4.2: Market by Device: Interventional Cardiology Devices and Peripheral Vascular Devices
4.4.3: Japanese Interventional Cardiology and Peripheral Vascular Device Market
4.4.4: Chinese Interventional Cardiology and Peripheral Vascular Device Market
4.4.5: Indian Cardiovascular Device Market
4.5: ROW Interventional Cardiology and Peripheral Vascular Device Market
4.5.1: Market by Type: Interventional Cardiology Devices and Peripheral Vascular Devices
4.5.2: Market by Device: Interventional Cardiology Devices and Peripheral Vascular Devices
4.5.3: Brazilian Interventional Cardiology and Peripheral Vascular Device Market
5. Competitor Analysis
5.1: Product Portfolio Analysis
5.2: Market Share Analysis
5.3: Operational Integration
5.4: Geographical Reach
5.5: Porter’s Five Forces Analysis
6. Cost Structure Analysis
6.1: Cost of Goods Sold
6.2: SG&A
6.3: EBITDA Margin
7. Growth Opportunities and Strategic Analysis
7.1: Growth Opportunity Analysis
7.1.1: Growth Opportunities for the Global Interventional Cardiology and Peripheral Vascular Device Market by Type
7.1.2: Growth Opportunities for the Global Interventional Cardiology and Peripheral Vascular Device Market by Region
7.2: Emerging Trends in the Global Interventional Cardiology and Peripheral Vascular Device Market
7.3: Strategic Analysis
7.3.1: New Product Development
7.3.2: Capacity Expansion of the Global Interventional Cardiology and Peripheral Vascular Device Market
7.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Interventional Cardiology and Peripheral Vascular Device Market
7.3.4: Technology Development
8. Company Profiles of Leading Players
8.1: Abbott Laboratories
8.2: Boston Scientific Corporation
8.3: Edwards Lifesciences Corporation
8.4: Medtronic Public Limited Company
8.5: C. R. Bard, Inc.
8.6: Cook Medical Inc.
8.7: Terumo Corporation
8.8: Cardinal Health Inc